Boc-L-Alanine N-hydroxysuccinimde ester

Boc-L-Alanine N-hydroxysuccinimde ester is a Boc-protected L-alanine activated as an N-hydroxysuccinimide (NHS) ester, combining an Fmoc/Boc-compatible amino acid building block motif with an acylating group designed for efficient coupling to nucleophiles. This protected, activated intermediate is widely used in peptide chemistry and synthetic bioconjugation workflows where controlled reactivity and minimized side reactions are important. The Boc group provides stability during handling and upstream steps, while the NHS ester enables rapid formation of amide bonds with primary amines under standard coupling conditions.

1. Peptide Coupling Building Block

Boc-L-Alanine N-hydroxysuccinimde ester is used as a reactive alanine source in peptide segment assembly and modified peptide synthesis workflows, particularly when an activated carboxylate is preferred over less reactive acid forms. Research groups assembling short peptides, alanine-containing fragments, or incorporating alanine at defined positions often select this NHS-activated intermediate to promote efficient amide bond formation during solution-phase coupling. The Boc-protected amino functionality supports compatibility with protected-peptide strategies, allowing the building block to be carried through multi-step sequences while maintaining the desired protection pattern for downstream deprotection and condensation steps.

2. Amine-Targeted Bioconjugation

Boc-L-Alanine N-hydroxysuccinimde ester is commonly employed in chemical biology and biomaterials research to introduce an alanine-derived acyl group onto amine-containing partners, such as lysine residues on proteins or primary amines on peptides and linkers. The NHS ester activation is leveraged to drive fast coupling to nucleophiles, enabling controlled functionalization of biomolecules for subsequent conjugation steps, affinity reagent preparation, or surface modification workflows. Because the product is an activated ester rather than a free amino acid, it is typically chosen when the goal is direct acylation of an amine-bearing substrate under mild conditions, followed by continuation to the next synthetic or conjugation stage.

3. Pharmaceutical Intermediate Derivatization

Boc-L-Alanine N-hydroxysuccinimde ester serves as a practical intermediate for medicinal chemistry and process development teams that need an alanine-derived acylating synthon for generating amide-containing structures. The NHS ester format provides a convenient activation state for preparing amide intermediates used in the synthesis of peptidomimetic scaffolds, solubilizing fragments, or other amide-linked building blocks. In development settings, the Boc protection helps maintain orthogonality during the early stages of intermediate construction, enabling selective advancement toward target molecules while minimizing premature reactions of the amino functionality.

4. Analytical Reference Material Preparation

Boc-L-Alanine N-hydroxysuccinimde ester is also used in analytical method development and characterization workflows where amide-forming standards or derivatized reference compounds are required. Laboratories preparing calibration materials for coupling efficiency studies, derivatization screening, or LC-MS method qualification often use activated amino acid esters to generate reproducible amide products from amine-containing analytes. The defined Boc protection and activated NHS ester chemistry support consistent derivatization outcomes, which is valuable when comparing coupling conditions, reagent lots, or downstream purification performance during method optimization.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy